Impact and effectiveness of the quadrivalent human papillomavirus vaccine: A systematic review of 10 years of real-world experience
Research output: Contribution to journal › Review › Research › peer-review
Standard
Impact and effectiveness of the quadrivalent human papillomavirus vaccine : A systematic review of 10 years of real-world experience. / Garland, Suzanne M; Kjaer, Susanne K.; Muñoz, Nubia; Block, Stan L; Brown, Darron R; Dinubile, Mark J.; Lindsay, Brianna R.; Kuter, Barbara J; Perez, Gonzalo; Dominiak-Felden, Geraldine; Saah, Alfred J; Drury, Rosybel; Das, Rituparna; Velicer, Christine.
In: Clinical Infectious Diseases, Vol. 63, No. 4, 2016, p. 519-527.Research output: Contribution to journal › Review › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Impact and effectiveness of the quadrivalent human papillomavirus vaccine
T2 - A systematic review of 10 years of real-world experience
AU - Garland, Suzanne M
AU - Kjaer, Susanne K.
AU - Muñoz, Nubia
AU - Block, Stan L
AU - Brown, Darron R
AU - Dinubile, Mark J.
AU - Lindsay, Brianna R.
AU - Kuter, Barbara J
AU - Perez, Gonzalo
AU - Dominiak-Felden, Geraldine
AU - Saah, Alfred J
AU - Drury, Rosybel
AU - Das, Rituparna
AU - Velicer, Christine
PY - 2016
Y1 - 2016
N2 - Prophylactic human papillomavirus (HPV) vaccination programs constitute major public health initiatives worldwide. We assessed the global effect of quadrivalent HPV (4vHPV) vaccination on HPV infection and disease. PubMed and Embase were systematically searched for peer-reviewed articles from January 2007 through February 2016 to identify observational studies reporting the impact or effectiveness of 4vHPV vaccination on infection, anogenital warts, and cervical cancer or precancerous lesions. Over the last decade, the impact of HPV vaccination in real-world settings has become increasingly evident, especially among girls vaccinated before HPV exposure in countries with high vaccine uptake. Maximal reductions of approximately 90% for HPV 6/11/16/18 infection, approximately 90% for genital warts, approximately 45% for low-grade cytological cervical abnormalities, and approximately 85% for high-grade histologically proven cervical abnormalities have been reported. The full public health potential of HPV vaccination is not yet realized. HPV-related disease remains a significant source of morbidity and mortality in developing and developed nations, underscoring the need for HPV vaccination programs with high population coverage.
AB - Prophylactic human papillomavirus (HPV) vaccination programs constitute major public health initiatives worldwide. We assessed the global effect of quadrivalent HPV (4vHPV) vaccination on HPV infection and disease. PubMed and Embase were systematically searched for peer-reviewed articles from January 2007 through February 2016 to identify observational studies reporting the impact or effectiveness of 4vHPV vaccination on infection, anogenital warts, and cervical cancer or precancerous lesions. Over the last decade, the impact of HPV vaccination in real-world settings has become increasingly evident, especially among girls vaccinated before HPV exposure in countries with high vaccine uptake. Maximal reductions of approximately 90% for HPV 6/11/16/18 infection, approximately 90% for genital warts, approximately 45% for low-grade cytological cervical abnormalities, and approximately 85% for high-grade histologically proven cervical abnormalities have been reported. The full public health potential of HPV vaccination is not yet realized. HPV-related disease remains a significant source of morbidity and mortality in developing and developed nations, underscoring the need for HPV vaccination programs with high population coverage.
KW - Cervical cancer
KW - CIN
KW - Gardasil/Silgard
KW - Genital warts
KW - HPV vaccination
U2 - 10.1093/cid/ciw354
DO - 10.1093/cid/ciw354
M3 - Review
C2 - 27230391
AN - SCOPUS:84982168442
VL - 63
SP - 519
EP - 527
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
SN - 1058-4838
IS - 4
ER -
ID: 179126851